Showing results (91-100 of 98) with videos related to
Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
NEJM Evidence|February 6, 2024
Abiraterone and Olaparib for Metastatic Castration-Resistant Prostate CancerNoel W Clarke, Andrew J Armstrong, Antoine Thiery-Vuillemin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2024
Randomized Phase II Study of Durvalumab with or without Tremelimumab in Patients with Metastatic Castration-Resistant Prostate CancerEric Winquist, Sebastien J Hotte, Kim Chi, et al.Journal of Geriatric Oncology|July 17, 2023
Implementing geriatric assessment and management for older Canadians with cancer: Adherence to and satisfaction with the intervention, results of the 5C studyMartine Puts, Jihad Abou Ali Waked, Fay Strohschein, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2022
Impact of Geriatric Assessment and Management on Quality of Life, Unplanned Hospitalizations, Toxicity, and Survival for Older Adults With Cancer: The Randomized 5C TrialMartine Puts, Naser Alqurini, Fay Strohschein, et al.BMJ Open|May 13, 2019
Clinical and Cost-effectiveness of a Comprehensive geriatric assessment and management for Canadian elders with Cancer-the 5C study: a study protocol for a randomised controlled phase III trialMartine T E Puts, Tina Hsu, Caroline Mariano, et al.Journal of Geriatric Oncology|February 5, 2025
Supporting older adults with cancer and their support person through geriatric assessment and remote exercise and education: The SOAR study protocolNirusha Jebanesan, Shabbir M H Alibhai, Daniel Santa Mina, et al.The Oncologist|February 23, 2024
Extended Safety and Tolerability of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer and Adverse Event Time Course in ARAMISNeal D Shore, Christian Gratzke, Susan Feyerabend, et al.The New England Journal of Medicine|February 16, 2023
Rucaparib or Physician's Choice in Metastatic Prostate CancerKarim Fizazi, Josep M Piulats, M Neil Reaume, et al.Pageof 10